Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR)

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jul 26, 2023

Keywords

ClinConnect Summary

The AVATAR trial is exploring how virtual reality (VR) can help reduce anxiety, pain, and the duration of a common medical procedure called bronchial fibroscopy (BF), which is used to examine the lungs in patients with respiratory issues. This study is particularly focused on patients in critical care who are awake and breathing on their own. By using VR, which can include soothing music and guided relaxation techniques, researchers hope to make this often stressful procedure more comfortable and less intimidating.

To participate in this trial, individuals must be adults over 18 years old, currently hospitalized in a critical care unit, and alert enough to engage in the study. They should be undergoing their first BF while in the hospital and must agree to take part by signing a consent form. Importantly, this study is not suitable for those with certain medical conditions, such as severe cognitive impairments, epilepsy, or serious visual or hearing issues. Participants can expect to use VR during the procedure, and the goal is to see if this technology can improve their overall experience and comfort during the examination.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults (over 18 years of age)
• • Hospitalized in a critical care unit (intensive care and intensive care)
• • Conscious (Glasgow score \>13)
• • Spontaneous ventilation
• • Requiring the realization of a FB
• • First BF during hospitalization
• • Having signed a consent to participate in the study
• • Affiliation to social security
• Exclusion Criteria:
• • Non-French-speaking patient
• • Protected minors or adults who cannot consent to participate
• • People with major neurocognitive impairment
• • Patient refusing to participate in the study
• • Patient on State medical aid
• • Patient under guardianship or curatorship or under judicial protection
• • BF for a vital emergency
• • Prior inclusion in the study
• • Pregnant or breastfeeding women
• • Presence of a tracheostomy or tracheostomy
• • Participation in other intervention research
• • Epilepsy
• • Visual impairment (blindness) or severe hearing impairment (hearing loss, deafness) that does not allow the use of the helmet
• • Psychiatric pathologies such as delusional disorders, hallucinations or schizophrenia.
• • Autism spectrum disorders
• • Patient sensitive to motion sickness
• • Refractory migraine under treatment